Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
974.3 DKK | +0.10% |
|
+0.61% | +39.22% |
11:17am | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.22% | 631B | |
+63.05% | 856B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.11% | 234B | |
+16.31% | 226B | |
+14.63% | 177B | |
+1.08% | 165B | |
+2.61% | 126B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Sector Update: Health Care Stocks Declining Late Wednesday